$VRME
VerifyMe Inc Stock $vrme

$vrme Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121465923004301 Filed on March 28, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$5.661M	$9.703M	$19.58M
YoY Change	3416.15%	3705.1%	2157.9%
Cost Of Revenue	$3.907M	$6.878M	$13.09M
YoY Change	10181.58%	7991.76%	4783.58%
Gross Profit	$1.754M	$2.825M	$6.488M
YoY Change	1326.02%	1561.76%	983.14%
Gross Profit Margin	30.98%	29.11%	33.14%
Selling, General & Admin	$3.250M	$2.709M	$10.15M
YoY Change	84.24%	125.75%	107.06%
% of Gross Profit	185.29%	95.89%	156.38%
Research & Development	$8.000K	$16.00K	$89.00K
YoY Change	-11.11%	-38.46%	74.51%
% of Gross Profit	0.46%	0.57%	1.37%
Depreciation & Amortization	$282.0K	$266.0K	$770.0K
YoY Change	705.71%	706.06%	558.12%
% of Gross Profit	16.08%	9.42%	11.87%
Operating Expenses	$3.258M	$2.725M	$10.24M
YoY Change	84.69%	116.44%	101.95%
Operating Profit	-$1.504M	$100.0K	-$3.747M
YoY Change	-8.35%	-109.18%	-16.16%
Interest Expense	-$75.00K	$5.000K	-$11.01M
YoY Change	-129.64%	-96.84%	-231.47%
% of Operating Profit		5.0%
Other Income/Expense, Net	-$76.00K	$3.000K	-$10.65M
YoY Change	-2633.33%		-226.15%
Pretax Income	-$1.580M	$108.0K	-$14.40M
YoY Change	13.34%	-110.75%	-498.67%
Income Tax
% Of Pretax Income
Net Earnings	-$1.580M	$108.0K	-$14.40M
YoY Change	13.34%	-110.76%	-498.62%
Net Earnings / Revenue	-27.91%	1.11%	-73.55%
Basic Earnings Per Share	-$0.17		-$1.70
Diluted Earnings Per Share	-$0.17	$0.01	-$1.70
COMMON SHARES
Basic Shares Outstanding	9.362M shares	9.035M shares	8.466M shares
Diluted Shares Outstanding	9.333M shares		8.466M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.085M	$3.411M	$3.411M
YoY Change	-64.03%	-63.8%	-63.8%
Cash & Equivalents	$3.085M	$3.411M	$3.411M
Short-Term Investments
Other Short-Term Assets	$367.0K	$333.0K	$333.0K
YoY Change	46.8%	38.75%	38.75%
Inventory	$54.00K	$81.00K	$81.00K
Prepaid Expenses
Receivables	$1.703M	$4.448M	$5.633M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.906M	$9.458M	$9.458M
YoY Change	-34.77%	-5.52%	-5.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$292.0K	$292.0K	$761.0K
YoY Change	55.32%	43.14%	273.04%
Goodwill	$1.383M	$3.988M
YoY Change
Intangibles
YoY Change
Long-Term Investments			$0.00
YoY Change			-100.0%
Other Assets	$160.0K	$133.0K	$133.0K
YoY Change
Total Long-Term Assets	$13.51M	$11.29M	$11.29M
YoY Change	13.83%	-3.28%	-3.28%
TOTAL ASSETS
Total Short-Term Assets	$5.906M	$9.458M	$9.458M
Total Long-Term Assets	$13.51M	$11.29M	$11.29M
Total Assets	$19.41M	$20.75M	$20.75M
YoY Change	-7.2%	-4.32%	-4.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.578M	$3.912M	$3.912M
YoY Change	159.11%	1047.21%	769.33%
Accrued Expenses	$891.0K	$902.0K	$1.017M
YoY Change		727.52%
Deferred Revenue
YoY Change
Short-Term Debt	$500.0K	$500.0K	$0.00
YoY Change
Long-Term Debt Due	$1.000M	$500.0K	$500.0K
YoY Change
Total Short-Term Liabilities	$3.809M	$5.429M	$5.429M
YoY Change	525.45%	1106.44%	1106.44%
LONG-TERM LIABILITIES
Long-Term Debt	$1.250M	$1.375M	$1.375M
YoY Change
Other Long-Term Liabilities	$1.390M	$362.0K	$362.0K
YoY Change	1003.17%	409.86%	409.86%
Total Long-Term Liabilities	$2.640M	$1.737M	$1.737M
YoY Change	1995.24%	2346.48%	2346.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.809M	$5.429M	$5.429M
Total Long-Term Liabilities	$2.640M	$1.737M	$1.737M
Total Liabilities	$6.449M	$7.166M	$7.166M
YoY Change	777.41%	1275.43%	1275.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$80.04M	-$78.46M
YoY Change		22.48%
Common Stock	$10.00K	$10.00K
YoY Change		42.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$793.0K	$949.0K
YoY Change		13.25%
Treasury Stock Shares
Shareholders Equity	$12.96M	$13.59M	$13.59M
YoY Change
Total Liabilities & Shareholders Equity	$19.41M	$20.75M	$20.75M
YoY Change	-7.2%	-4.32%	-4.32%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.580M	$108.0K	-$14.40M
YoY Change	13.34%	-110.76%	-498.62%
Depreciation, Depletion And Amortization	$282.0K	$266.0K	$770.0K
YoY Change	705.71%	706.06%	558.12%
Cash From Operating Activities	-$126.0K	$117.0K	-$2.551M
YoY Change	-87.41%	-113.21%	-21.6%
INVESTING ACTIVITIES
Capital Expenditures	$13.00K	$116.0K
YoY Change	-154.17%	-290.16%
Acquisitions	$363.0K		$7.500M
YoY Change
Other Investing Activities	-$399.0K	-$21.00K	-$7.608M
YoY Change			188.4%
Cash From Investing Activities	-$621.0K	-$137.0K	-$7.884M
YoY Change	2487.5%	124.59%	176.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$423.0K	-263.0K	$4.424M
YoY Change	1075.0%	0.77%	-41.7%
NET CHANGE
Cash From Operating Activities	-$126.0K	117.0K	-$2.551M
Cash From Investing Activities	-$621.0K	-137.0K	-$7.884M
Cash From Financing Activities	$423.0K	-263.0K	$4.424M
Net Change In Cash	-$326.0K	-283.0K	-$6.011M
YoY Change	-67.04%	-76.57%	-505.33%
FREE CASH FLOW
Cash From Operating Activities	-$126.0K	$117.0K	-$2.551M
Capital Expenditures	$13.00K	$116.0K
Free Cash Flow	-$139.0K	$1.000K	-$2.551M
YoY Change	-85.77%	-100.12%	-16.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001104038
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	vrme	Unbilled Revenue UnbilledRevenue		usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments		usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2021Q4	us-gaap	Debt Current DebtCurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2021	vrme	Loss On Equity Investment LossOnEquityInvestment		usd
CY2021	us-gaap	Other Income OtherIncome		usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	vrme	Payroll Protection Program Debt Forgiveness PayrollProtectionProgramDebtForgiveness		usd
CY2021	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap		usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	vrme	Fair Value Of Options Issued In Exchange For Services FairValueOfOptionsIssuedInExchangeForServices		usd
CY2022	us-gaap	Conversion Gains And Losses On Foreign Investments ConversionGainsAndLossesOnForeignInvestments		usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue		usd
CY2022	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease		usd
CY2022	vrme	Purchase Of Equity Investment PurchaseOfEquityInvestment		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2021	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2021	vrme	Equity Received From Spac Equity Investment EquityReceivedFromSpacEquityInvestment		usd
CY2021	vrme	Deferred Implementation Costs DeferredImplementationCosts		usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans		usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	vrme	Initial Recognition Of Rightofuse Asset And Lease Liability During Period InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod		usd
CY2021	vrme	Noncash Change In Fair Value Of Interest Rate Swap NoncashChangeInFairValueOfInterestRateSwap		usd
CY2021Q4	vrme	Book Value BookValue		usd
CY2021	vrme	Change In State Tax Rate ChangeInStateTaxRate		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	vrme	Stock Purchase Plan Spp StockPurchasePlanSpp		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2021Q4	vrme	Acquisition Transaction Costs AcquisitionTransactionCosts		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts		usd
CY2021Q4	vrme	Bad Debt BadDebt		usd
CY2021Q4	vrme	Dividend Income DividendIncome		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2021	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations		shares
CY2021	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice
CY2022	vrme	Amount Of Dilutive Securities Esop Convertible Preferred Stock Shares1 AmountOfDilutiveSecuritiesESOPConvertiblePreferredStockShares1		shares
CY2022	vrme	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Shares1 AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsShares1		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans		shares
CY2022	vrme	Restricted Stock Units Restricted Stock Awards RestrictedStockUnitsRestrictedStockAwards		shares
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q4	vrme	Total Operating Lease Liabilities TotalOperatingLeaseLiabilities		usd
CY2021Q4	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities		usd
CY2021Q4	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39332
CY2022	dei	Entity Registrant Name EntityRegistrantName	VERIFYME, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-3023677
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	801 International Parkway
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Fifth Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Lake Mary
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32746
CY2022	dei	City Area Code CityAreaCode	(585)
CY2022	dei	Local Phone Number LocalPhoneNumber	736-9400
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	14839432000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9361772	shares
CY2022	dei	Auditor Firm AuditorFirmId	206
CY2022	dei	Auditor Name AuditorName	MaloneBailey, LLP
CY2022	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3411000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9422000	usd
CY2022Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	37000	usd
CY2021Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	0	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4448000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	297000	usd
CY2022Q4	vrme	Unbilled Revenue UnbilledRevenue	1185000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	333000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	240000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	81000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	52000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9458000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	10011000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	10964000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	292000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	204000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	469000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6412000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	509000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3988000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	133000	usd
CY2022Q4	us-gaap	Assets Assets	20752000	usd
CY2021Q4	us-gaap	Assets Assets	21688000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	500000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3912000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	341000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	902000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	109000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5429000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	450000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	71000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1375000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7166000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	521000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9341002	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7420633	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8951035	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7196677	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92987000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	86059000	usd
CY2022Q4	vrme	Treasury Stocks Share TreasuryStocksShare	389967	shares
CY2021Q4	vrme	Treasury Stocks Share TreasuryStocksShare	223956	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	949000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	838000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78459000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-64061000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13586000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21167000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20752000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21688000	usd
CY2022	us-gaap	Revenues Revenues	19576000	usd
CY2021	us-gaap	Revenues Revenues	867000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	13088000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	268000	usd
CY2022	us-gaap	Gross Profit GrossProfit	6488000	usd
CY2021	us-gaap	Gross Profit GrossProfit	599000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8428000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4216000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	89000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1718000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1163000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	10235000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	5430000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3747000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4831000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-88000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2000	usd
CY2022	vrme	Loss On Equity Investment LossOnEquityInvestment	-10932000	usd
CY2022	vrme	Unrealized Gain On Equity Investment UnrealizedGainOnEquityInvestment	12000	usd
CY2021	vrme	Unrealized Gain On Equity Investment UnrealizedGainOnEquityInvestment	8371000	usd
CY2022	us-gaap	Other Income OtherIncome	31000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	326000	usd
CY2021	vrme	Payroll Protection Program Debt Forgiveness PayrollProtectionProgramDebtForgiveness	70000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10651000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8443000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3612000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.70
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.70
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8466075	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7110907	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8466075	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7383364	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3612000	usd
CY2022	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	-3000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14401000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3612000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3612000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	37000	usd
CY2022	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	145000	usd
CY2021	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	151000	usd
CY2021	vrme	Fair Value Of Options Issued In Exchange For Services FairValueOfOptionsIssuedInExchangeForServices	85000	usd
CY2022	vrme	Fair Value Of Restricted Stock Issued For Services FairValueOfRestrictedStockIssuedForServices	239000	usd
CY2021	vrme	Fair Value Of Restricted Stock Issued For Services FairValueOfRestrictedStockIssuedForServices	784000	usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	1084000	usd
CY2021	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	696000	usd
CY2021	us-gaap	Conversion Gains And Losses On Foreign Investments ConversionGainsAndLossesOnForeignInvestments	70000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-10932000	usd
CY2022	vrme	Unrealized Gain On Equity Investment UnrealizedGainOnEquityInvestment	12000	usd
CY2021	vrme	Unrealized Gain On Equity Investment UnrealizedGainOnEquityInvestment	8371000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	326000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	770000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	117000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3352000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	354000	usd
CY2022	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue	-1185000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	29000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	77000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-25000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3621000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	69000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2551000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3254000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	40000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	95000	usd
CY2021	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	45000	usd
CY2021	vrme	Purchase Of Equity Investment PurchaseOfEquityInvestment	2593000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12000	usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	7500000	usd
CY2022	vrme	Equity Received From Spac Equity Investment EquityReceivedFromSpacEquityInvestment	32000	usd
CY2022	vrme	Deferred Implementation Costs DeferredImplementationCosts	140000	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	236000	usd
CY2021	us-gaap	Payments For Software PaymentsForSoftware	106000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7884000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2851000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4528000	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	8447000	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	2000000	usd
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-3000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	102000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	34000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	131000	usd
CY2022	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	291000	usd
CY2021	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	725000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	1882000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4424000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7588000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6011000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1483000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9422000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7939000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3411000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9422000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	33000	usd
CY2022	vrme	Initial Recognition Of Rightofuse Asset And Lease Liability During Period InitialRecognitionOfRightofuseAssetAndLeaseLiabilityDuringPeriod	552000	usd
CY2022	vrme	Noncash Change In Fair Value Of Interest Rate Swap NoncashChangeInFairValueOfInterestRateSwap	-3000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	8319000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	85000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	654000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	696000	usd
CY2021	vrme	Stock Purchase Plan1 StockPurchasePlan1	40000	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	39000	usd
CY2021	vrme	Stock Issued During Period Value Common Stock Issued In Relation To Public Offering Of Securities StockIssuedDuringPeriodValueCommonStockIssuedInRelationToPublicOfferingOfSecurities	8447000	usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	725000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3612000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21167000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	21167000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	205000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1084000	usd
CY2022	vrme	Stock Purchase Plan1 StockPurchasePlan1	121000	usd
CY2022	vrme	Common Stock Issued In Relation To Stock Purchase Plan CommonStockIssuedInRelationToStockPurchasePlan	102000	usd
CY2022	vrme	Common Stock Issued In Relation To Private Placement CommonStockIssuedInRelationToPrivatePlacement	4528000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	96000	usd
CY2022	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	974000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	291000	usd
CY2022	vrme	Exercise Of Prefunded Warrants ExerciseOfPrefundedWarrants	1000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13586000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_z4bRz1B5JNDa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86E_zUB5xaVrqFy8">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	657000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	64000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3854000	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	838000	usd
CY2022Q1	vrme	Nonqualified Stock Purchase Plan NonqualifiedStockPurchasePlan	25000	shares
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	33000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	22000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	9000	usd
CY2022Q4	us-gaap	Cash Cash	63000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	37000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	vrme	Acquisition Transaction Costs AcquisitionTransactionCosts	110000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	17000	usd
CY2022	us-gaap	Reclassifications Reclassifications	<p id="xdx_847_eus-gaap--Reclassifications_z5wS2JnH9Fsa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_863_zR32dygDmrak">Reclassifications</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain accounts in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in the current year financial statements. These reclassifications had no effect on the previously reported net income (loss).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	1000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	2188000	usd
CY2022Q4	vrme	Bad Debt BadDebt	9000	usd
CY2022Q4	vrme	Dividend Income DividendIncome	-2000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7652000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	60000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	51000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	89000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	0	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	11000000.0	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	10932000	usd
CY2022	vrme	Equity Investments Fair Value EquityInvestmentsFairValue	12000	usd
CY2022Q4	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	100000	usd
CY2021Q4	vrme	Equity Investments Fair Value1 EquityInvestmentsFairValue1	88000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3854000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7652000	usd
CY2022	us-gaap	Revenues Revenues	19576000	usd
CY2021	us-gaap	Revenues Revenues	867000	usd
CY2022Q2	vrme	Business Combination Consideration Transferred BusinessCombinationConsiderationTransferred	7500000	usd
CY2022	vrme	Revenue1 Revenue1	25397000	usd
CY2021	vrme	Revenue1 Revenue1	29500000	usd
CY2022	vrme	Net Income Loss1 NetIncomeLoss1	-14298000	usd
CY2021	vrme	Net Income Loss1 NetIncomeLoss1	5465000	usd
CY2022	us-gaap	Acquisition Costs AcquisitionCosts	3988000	usd
CY2022Q4	vrme	Book Value BookValue	3988000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7473000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1061000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6412000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	913000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-404000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	509000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1057000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	877000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	857000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	842000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	836000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1943000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6412000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14400000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3612000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3024000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	759000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1188000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-6149000	usd
CY2022	vrme	Change In State Tax Rate ChangeInStateTaxRate	-57000	usd
CY2022	vrme	Income Tax Reconciliation All Other IncomeTaxReconciliationAllOther	5045000	usd
CY2021	vrme	Income Tax Reconciliation All Other IncomeTaxReconciliationAllOther	5204000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-776000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	186000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6495000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5208000	usd
CY2022Q4	vrme	Restricted Stock Rsas Rsus RestrictedStockRsasRsus	503000	usd
CY2021Q4	vrme	Restricted Stock Rsas Rsus RestrictedStockRsasRsus	180000	usd
CY2022Q4	vrme	Stock Options StockOptions	562000	usd
CY2021Q4	vrme	Stock Options StockOptions	678000	usd
CY2022Q4	vrme	Stock Purchase Plan Spp StockPurchasePlanSpp	8000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	71000	usd
CY2022	vrme	Description Of Ownership Change DescriptionOfOwnershipChange	Utilization of the net operating losses (NOL) carryforwards may be subject to a substantial annual limitation as required by Section 382 of the IRC, due to ownership change of the company that could occur in the future, as well as similar state provisions. In general, an “ownership change” as defined by Section 382 results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders. These ownership changes may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income.
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.266	pure
CY2022Q4	vrme	Deferred Tax Assets Valuation Allowance1 DeferredTaxAssetsValuationAllowance1	7700000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2021Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	326000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1958000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.07602	pure
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	500000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1400000	usd
CY2021	vrme	Loan Forgiveness Amount LoanForgivenessAmount	69000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3000	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	239000	usd
CY2021	us-gaap	Restricted Stock Expense RestrictedStockExpense	784000	usd
CY2022	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	1084000	usd
CY2021	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	696000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	96000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	39000	usd
CY2022Q3	vrme	Prefunded Warrants PrefundedWarrants	675000	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.001
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	675000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	675000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	305473	shares
CY2022	vrme	Nonqualified Stock Purchase Plan Expenses NonqualifiedStockPurchasePlanExpenses	122000	usd
CY2021	vrme	Nonqualified Stock Purchase Plan Expenses NonqualifiedStockPurchasePlanExpenses	40000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	389967	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	223956	shares
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	949000	usd
CY2022Q1	vrme	Nonqualified Stock Purchase Exercise Price NonqualifiedStockPurchaseExercisePrice	2.69
CY2022Q3	vrme	Nonqualified Stock Purchase Plan NonqualifiedStockPurchasePlan	28895	shares
CY2022Q3	vrme	Nonqualified Stock Purchase Exercise Price NonqualifiedStockPurchaseExercisePrice	1.20
CY2020Q4	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	1500000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3779243	shares
CY2020Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	5.89
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3779243	shares
CY2021Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	5.89
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	1590150	shares
CY2022	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice	3.22
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	265938	shares
CY2022	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice	19.21
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5103455	shares
CY2022Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.34
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y
CY2022Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	5103455	shares
CY2022Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	4.34
CY2022	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms	P3Y
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3612000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8466075	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7110907	shares
CY2021	vrme	Amount Of Dilutive Securities Esop Convertible Preferred Stock Shares1 AmountOfDilutiveSecuritiesESOPConvertiblePreferredStockShares1	144444	shares
CY2021	vrme	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units Shares1 AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnitsShares1	48212	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	23	shares
CY2021	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	2362	shares
CY2021	vrme	Restricted Stock Units Restricted Stock Awards RestrictedStockUnitsRestrictedStockAwards	77416	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8466075	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7383364	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.70
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.70
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	71000	usd
CY2022	us-gaap	Long Term Debt Description LongTermDebtDescription	The fair value of the derivative liability associated with the interest rate swap was $3 thousand as of December 31, 2022, and $0 as of December 31, 2021.
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	103000	usd
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	10000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	85000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	18000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	14000	usd
CY2022	us-gaap	Lease Cost LeaseCost	103000	usd
CY2021	us-gaap	Lease Cost LeaseCost	14000	usd
CY2021	us-gaap	Revenues Revenues	867000	usd
CY2022	us-gaap	Gross Profit GrossProfit	6488000	usd
CY2021	us-gaap	Gross Profit GrossProfit	599000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	469000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359000	usd
CY2022Q4	vrme	Total Operating Lease Liabilities TotalOperatingLeaseLiabilities	474000	usd
CY2022Q4	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities	80000	usd
CY2022Q4	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities	552000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	122000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	126000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	130000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	134000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	45000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	557000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	83000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	474000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	359000	usd
CY2022	us-gaap	Revenues Revenues	19576000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8428000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4216000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	89000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	51000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1718000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1163000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3747000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4831000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10651000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8443000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14398000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	3612000	usd
CY2022Q4	us-gaap	Assets Assets	20752000	usd
CY2021Q4	us-gaap	Assets Assets	21688000	usd

Files In Submission

Name	View Source	Status
0001214659-23-004301-index-headers.html	Edgar Link	pending
0001214659-23-004301-index.html	Edgar Link	pending
0001214659-23-004301.txt	Edgar Link	pending
0001214659-23-004301-xbrl.zip	Edgar Link	pending
ex21_1.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex4_8.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vm32123010k.htm	Edgar Link	pending
vrme-20221231.xsd	Edgar Link	pending
vrme-20221231_cal.xml	Edgar Link	unprocessable
vrme-20221231_def.xml	Edgar Link	unprocessable
vrme-20221231_lab.xml	Edgar Link	unprocessable
vrme-20221231_pre.xml	Edgar Link	unprocessable
vm32123010k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRME
VerifyMe Inc Stock $vrme

2023 Q1 Form 10-K Financial Statement

#000121465923004301 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME VerifyMe Inc Stock $vrme

2023 Q1 Form 10-K Financial Statement

#000121465923004301 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME
VerifyMe Inc Stock $vrme